Publication: Acute Vaginal Candidiasis: A review of treatment guidelines and Siriraj experience
Issued Date
2021-11-01
Resource Type
ISSN
26730871
08576084
08576084
Other identifier(s)
2-s2.0-85122708644
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Thai Journal of Obstetrics and Gynaecology. Vol.29, No.6 (2021), 306-312
Suggested Citation
Chenchit Chayachinda, Thanapa Rekhawasin, Manopchai Thamkhantho, Payaow Aneklap Acute Vaginal Candidiasis: A review of treatment guidelines and Siriraj experience. Thai Journal of Obstetrics and Gynaecology. Vol.29, No.6 (2021), 306-312. doi:10.14456/tjog.2021.36 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77677
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Acute Vaginal Candidiasis: A review of treatment guidelines and Siriraj experience
Other Contributor(s)
Abstract
Acute vaginal candidiasis (VC) is a leading cause of abnormal vaginal discharge at gynecologic clinics. The most common causative organism is Candida albicans, which is one of the vaginal normal flora. Therefore, VC is not considered as being a sexually-transmitted disease (STD). Host factors such as a disturbance of vaginal ecosystem, a prolonged use of antibiotics and individual hormonal effect appear to precipitate the condition. Although symptoms and signs of VC are unique, the diagnosis also requires a basic tool like a microscope. Azole antifungals are recommended as the first-line treatment in all guidelines. However, lifestyle modification is apparently as important. As the Siriraj Female STD Clinic (Clinic 309) has been taking of this group of patients and has conducted some clinical trials on this issue, we would like to review current treatment guidelines of acute VC and to share some of our experience.